Comparison Overview
Glenmark Pharmaceuticals
Glenmark Pharmaceuticals
Glenmark House, B.D.Sawant Marg,, Chakala, Andheri (East), Mumbai, Maharashtra, IN, 400099
Last Update: 29/04/2026
Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our jou...
Novo Nordisk
Novo Alle, Bagsværd, 2880, DK
Last Update: 13/07/2026
We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more acces...
Compliance Ranges Comparison
Glenmark Pharmaceuticals
Novo Nordisk
Benchmark & Cyber Underwriting Signals
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
Glenmark Pharmaceuticals has 34.64% fewer incidents than the average of same-industry companies with at least one recorded incident.
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
Novo Nordisk has 188.46% more incidents than the average of all companies with at least one recorded incident.
Incident History - Glenmark Pharmaceuticals (X = Date, Y = Severity)
Glenmark Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Novo Nordisk (X = Date, Y = Severity)
Novo Nordisk cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents
Glenmark Pharmaceuticals
Novo Nordisk
FAQ
Latest Global CVEs
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerability which could allow an attacker to steal admin credentials via weak hash or a pass-the-hash attack.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could allow for asset discovery by unauthenticated users.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.
Pronetiqs IntraVUE Versions 3.2.1a14 and prior have a plaintext storage of a password vulnerability that could expose cleartext credentials through the API.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could expose the underlying host/share filesystem.